Limbach Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Limbach Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $646.80M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $518.78M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $516.35M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $496.78M | Mar 10, 2025 |
| FY2022 | Dec 31, 2021 | $490.35M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $568.21M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $553.33M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $546.53M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $485.74M | Apr 15, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $485.74M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $225.60M | Apr 2, 2018 |
| FY2015 | Dec 31, 2015 | $0 | Mar 21, 2016 |
| FY2015 | Dec 31, 2014 | $0 | Mar 21, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $169.31M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $144.28M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $119.29M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $93.74M | Mar 10, 2025 |
| FY2022 | Dec 31, 2021 | $85.91M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $81.39M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $71.88M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $59.43M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $65.62M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $27.18M | Apr 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.06M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $30.88M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $20.75M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $6.80M | Mar 10, 2025 |
| FY2022 | Dec 31, 2021 | $6.71M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $5.81M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($1.78M) | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | ($1.85M) | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $712.0K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($698.0K) | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.45M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $38.62M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $29.28M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $12.01M | Mar 10, 2025 |
| FY2022 | Dec 31, 2021 | $13.99M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $17.16M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $8.07M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.07M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $6.02M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($351.0K) | Apr 2, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.52M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $97.20M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $87.40M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $77.88M | Mar 10, 2025 |
| FY2022 | Dec 31, 2021 | $71.44M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $63.60M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $63.17M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $57.09M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $56.02M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $24.43M | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.70M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $36.78M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $57.37M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $35.37M | Mar 10, 2025 |
| FY2022 | Dec 31, 2021 | ($24.23M) | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $39.82M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($926.0K) | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $25.32M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | ($4.07M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $3.11M | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.81M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $7.52M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $2.27M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $993.0K | Mar 10, 2025 |
| FY2022 | Dec 31, 2021 | $791.0K | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $1.48M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $2.66M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $3.88M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $3.30M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $1.28M | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $381.13M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $352.13M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $304.44M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $294.56M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $267.51M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $262.16M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $261.62M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $253.63M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $213.02M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $206.88M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $185.47M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $198.64M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $183.52M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $199.11M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $179.67M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $208.43M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $214.75M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $207.27M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | $156.90M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $149.05M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $195.66M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $153.49M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $120.92M | Mar 2, 2026 |
| FY2025 | Dec 31, 2022 | $95.44M | Mar 2, 2026 |
| FY2024 | Dec 31, 2021 | $87.84M | Mar 10, 2025 |
| FY2022 | Dec 31, 2020 | $53.73M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $46.87M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $46.37M | Mar 25, 2021 |
| FY2019 | Dec 31, 2017 | $48.16M | May 12, 2020 |
| FY2018 | Dec 31, 2016 | $47.45M | Apr 15, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $70.60M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $33.03M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $16.37M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $11.37M | Mar 10, 2025 |
| FY2023 | Dec 31, 2021 | $11.37M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $6.13M | Mar 8, 2023 |
| FY2020 | Dec 31, 2019 | $6.13M | Mar 25, 2021 |
| FY2020 | Dec 31, 2018 | $10.49M | Mar 25, 2021 |
| FY2018 | Dec 31, 2017 | $10.49M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $10.49M | Apr 2, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.33M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $61.26M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $30.39M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $9.63M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $2.83M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | ($3.88M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($9.69M) | Mar 25, 2021 |
| FY2019 | Jan 1, 2019 | ($7.91M) | May 12, 2020 |
| FY2019 | Dec 31, 2018 | ($8.42M) | May 12, 2020 |
| FY2018 | Dec 31, 2017 | ($6.58M) | Apr 15, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.35M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $44.93M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $59.83M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $36.00M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $14.48M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $42.15M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $8.34M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.62M | May 12, 2020 |
| FY2017 | Dec 31, 2017 | $626.0K | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $7.41M | Apr 2, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $47.59M | May 12, 2020 |
| FY2018 | Dec 31, 2018 | $27.22M | Apr 15, 2019 |
| FY2018 | Dec 31, 2017 | $27.12M | Apr 15, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 10, 2025 |
| FY2022 | Dec 31, 2021 | 0 | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | 0 | May 12, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 10, 2025 |
| FY2022 | Dec 31, 2021 | 0 | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | 0 | May 12, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.63M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 11.27M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 11.00M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | 10.29M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | 10.30M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | 7.93M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | 7.69M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | 7.59M | May 12, 2020 |
| FY2018 | Dec 31, 2017 | 7.50M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | 7.45M | Apr 2, 2018 |